Aytu Biopharma (AYTU) Profit After Tax Growth (3y) (2014 - 2026)
Aytu Biopharma (AYTU) Profit After Tax Growth (3y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.05 Bn | 43.08 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.39 Bn | 39.74 Bn | 2.15 Bn | 14.01% |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn | -0.23% |
| 4 | Takeda Pharmaceutical | 28.78 Bn | 22.99 Bn | 5.10 Bn | 2.89% |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn | 8.71% |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | -34.81% |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | 15.37% |
| 8 | Elanco Animal Health | 11.92 Bn | 11.39 Bn | 798.00 Mn | 36.74% |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 9.99 Bn | - | - |
| 10 | Aytu Biopharma | 24.75 Mn | -1.96 Mn | 7.60 Mn | 7.94% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.94% |
| Dec 31, 2025 | -16.50% |
| Sep 30, 2025 | 68.72% |
| Jun 30, 2025 | -8.30% |
| Mar 31, 2025 | 27.55% |
| Dec 31, 2024 | 27.41% |
| Sep 30, 2024 | 27.09% |
| Jun 30, 2024 | 59.17% |
| Dec 31, 2023 | 71.50% |
| Sep 30, 2023 | -23.60% |
| Jun 30, 2023 | 12.23% |
| Mar 31, 2023 | -10.53% |
| Dec 31, 2022 | -214.95% |
| Sep 30, 2022 | 47.80% |
| Jun 30, 2022 | 14.05% |
| Mar 31, 2022 | -128.01% |
| Dec 31, 2021 | -35.35% |
| Sep 30, 2021 | -100.67% |
| Jun 30, 2021 | -232.51% |
| Dec 31, 2020 | -37.27% |